Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine in binge eating disorder
NCT00327834Phase 4Completed
- Sponsor
- Lindner Center of HOPE
- Start
- May 2006
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atomoxetine in binge eating disorder (BED), sponsored by Lindner Center of HOPE. Started May 2006; status: completed.
02
Drugs
atomoxetine
03
Conditions
binge eating disorder (BED)
Beyond the preview
Go deeper on NCT00327834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00327834.